🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Vocal Biomarkers of Craving

Recruitingn/aAges 18 Years - anyAllUniversity of Bordeaux
NCT07878624 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Addiction is a psychiatric disorder associated with craving, an unwanted, intense and persistent desire to use the substance/addictive behavior, leading to frequent relapses. Craving is fluctuating, influenced by internal factors or environmental context, and can be evaluated only by self-report which can be burdensome. It has been shown that craving predicts relapse, making it a major treatment target in addiction. Identify biomarkers of craving could enable to detect craving in a passive way (without major effort from individuals to report it) and would be a major improvement. The goal of this observational study is to explore if voice could be a biomarker of craving in adults with substance or behavioral addictions. The main question it aims to answer is: • Is there voice features associated with craving episodes in addiction ? Participants will undergo a cue-reactivity protocol with

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Identify at least one main problematic substance (cannabis, tobacco, alcohol, opiates, stimulant) or one main problematic addictive behavior (e.g : video games, gambling, food, sex…) as the primary addiction * PresentDiagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) diagnosis for current Use Disorder for this primary addiction * Report regular craving and use of this primary addiction (more than 10 days in the last 30 days) * For participants recruited in treatment centers: receive outpatient treatment for this primary addiction
💊

What it tests

  • Cue reactivity paradigm
  • Ecological momentary assessment
📍

Where

1 site
Université de Bordeaux CNRS UMR 6033 SANPSY
Bordeaux, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy